Susquehanna International Group, LLP Organogenesis Holdings Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$2.61 - $4.49 $9,135 - $15,715	-3,500 Reduced 14.96%	19,900 $56,000
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $46,098 - $98,514	23,400 New	23,400 $95,000
Q4 2022 Feb 14, 2023	SELL	$2.48 - $3.43 $17,360 - $24,010	-7,000 Reduced 34.83%	13,100 $35,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $6.43 $31,400 - $64,300	-10,000 Reduced 33.22%	20,100 $65,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $67,308 - $115,730	-14,200 Reduced 32.05%	30,100 $147,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $43,996 - $65,076	6,800 Added 18.13%	44,300 $338,000
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $312,092 - $467,100	-34,600 Reduced 47.99%	37,500 $347,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $647,112 - $810,896	47,200 Added 189.56%	72,100 $1.03 Million
Q2 2021 Aug 11, 2021	BUY	$14.92 - $23.23 $371,508 - $578,427	24,900 New	24,900 $414,000

125

71.6M

15.1K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $593M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.